Federal contractor · NEWARK, CA

MALCOVA INC

MALCOVA INC received $1M in federal contract obligations in FY2026, on 1 awards. Since FY2023: $3M. Its largest customer was Food and Drug Administration ($1M).

Obligations · FY2026
$1M
New awards
1
Sole-source
0.0%
Single offer
100%
UEI
GSB6L7B1FB13
Other than small businessWoman-ownedMinority-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 2MFY2023
  2. 1MFY2026

Top buying agencies

Obligations in FY2026.

  1. Food and Drug Administration$1M100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$1M100%

Where the work was performed

  1. Alameda County, CA$1M100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $1M
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions100%
    US 8.8% · $1M
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. PROPOSED RESEARCH QUALIFIES AS DEVELOPMENT (PER ITS DEFINITION IN FAR 35.001) AS PRIMARY FOCUS OF THE PROPOSED PROJECT IS ON DEVELOPING A DIGITAL TWIN MODEL, FOR EVALUATION OF BREAST CANCER IMAGING MODALITIES.$1M
    Food and Drug Administration· Alameda County, CA· Research & development· Jun 3, 2026 – Jun 3, 2026· 75F40126C00019

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

MALCOVA INC received $0 in federal assistance in FY2026, on 1 actions (0 new awards), −100% vs FY2025.

Assistance · FY2026
$0
New awards
0
Actions
1
Since FY2023
$3M

Assistance by fiscal year

  1. 1MFY2023
  2. 1.1MFY2024
  3. 854KFY2025
  4. 0FY2026

Largest awards

  1. A COMPREHENSIVE IMAGING SOLUTION FOR DENSE BREAST CANCER SCREENING AND DIAGNOSTICS - PROJECT SUMMARY OUR OVERARCHING GOAL IN THIS PROJECT…$2M
    93.394 · Cancer Detection and Diagnosis Research· National Institutes of Health· Project grant· Jul 15, 2024 – May 4, 2026· R44CA261381

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2023–FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. SPAULDING CLINICAL RESEARCH, LLC$1M
    WEST BEND, WI · 99.6% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  2. THE TASK FORCE FOR GLOBAL HEALTH, INC.$995.4K
    DECATUR, GA · 99% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  3. HKS INC$1.3M
    DALLAS, TX · 100% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.